Proteasome-IN-4
Proteasome-IN-4 is an excellent and non-covalent proteasome inhibitor (IC50=8.39 nM) . Proteasome-IN-4 has potent antiproliferative activities against RPMI-8226, MM-1S and MV-4-11 cell lines. Proteasome-IN-4 can be used for cancer research[1].
Product Specifications
UNSPSC
12352005
Target
Proteasome
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/proteasome-in-4.html
Solubility
10 mM in DMSO
Smiles
CCN(C1=CC=CC=C1)C(C2CCN(CC2)C(N[C@H](C(N[C@H](C(N[C@@H]3CCCC4=C3C=CC=C4)=O)CCC5=CC=CC=C5)=O)CC(NCC(C)(C)C)=O)=O)=O
Molecular Formula
C44H58N6O5
Molecular Weight
750.97
References & Citations
[1]Cao Y, et al. Metabolism guided optimization of peptidomimetics as non-covalent proteasome inhibitors for cancer treatment. Eur J Med Chem. 2022;233:114211.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
321901 100 µL
HEC1 (Kinetochore Protein NDC80 Homolog, Highly expressed in Cancer Protein, Kinetochore Protein Hec1, HsHec1, Kinetochore-Associated Protein 2, Retinoblastoma-Associated Protein HEC, NDC80, HEC1, KNTC2)
Ask
View Details 
GTR15292460 1 Vial
Lentiviral mouse Slc38a1 shRNA (UAS) - Lentiviral mouseSlc38a1 shRNA (UAS, GFP) (25)
Ask
View Details